Brain cancer vaccine complete successful phase 1 trials | The Optimist Daily
Today’s Solutions: June 22, 2024

Diffuse gliomas are a type of brain cancer that is especially difficult to treat, but 70 percent of low-grade gliomas have a single gene mutation that affects an isocitrate dehydrogenase 1 (IDH1) enzyme. This is what allowed German Cancer Research Center scientist Michael Platten to create a vaccine to potentially treat this cancer which has now completed phase 1 trials. 

The vaccine works by training the immune system to target the IDH1 mutated cells. Phase 1, which started in 2015, determined that the vaccine was safe in all 33 trial participants and initiated an effective response to the vaccine in 93 percent of patients. Among those who responded to the vaccine, T cells specifically targeting the IDH1 mutation were present. 

After three years, the survival rate among the initial cohort is 84 percent and there was no documented tumor growth in 82 percent of patients. These initial results are very encouraging. As the vaccine moves to phase 2 trials, with larger sample sizes, researchers hope they will soon have a vaccine capable of treating a majority of diffuse glioma patients.

Solutions News Source Print this article
More of Today's Solutions

Could “antivitamins” be the cure to antibiotic resistance?

The first naturally-occurring bacteria killer, penicillin, was discovered nearly a century ago and with it came the advent of a new class of medicines: ...

Read More

Pittsburgh will become a dark sky city in 2022

Anyone who lives in a big city knows that stars are a rare sight due to light pollution, but that may soon change in ...

Read More

5 simple yet profound ways to make the world a better place today

The word activism can bring up images of aggression and vehemence, but it turns out that activism can be practiced in gentle ways, too. ...

Read More

Removable solar panels might soon be rolled out on railway tracks

Solar panels are being laid out "like carpet" across Swiss train rails as part of the country's renewable energy initiative. Swiss startup company Sun-Ways ...

Read More